STAT3 and colorectal cancer: Through the validation of differential gene expression in the GEPIA database, we found that the validation of MYC and STAT3 in the GEPIA database yielded the same results as the GEO database, which could be able to serve as targets to play a role as tumor marker in colorectal cancer.